From: Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
Gleason stage
Survivin
Less than 3+ (%)
3+ (%)
Total
<7
31 (62)
15 (34.1)
46 (48.9)
≥7
19 (38)
29 (65.9)
48 (51.1)
50 (100)
44 (100)
94 (100)